
MGC Pharma receives first tranche of funding under new $10m financing facility
The financing facility will fund the execution of MGC Pharma’s business commercialisation strategy in the UK and US.
The financing facility will fund the execution of MGC Pharma’s business commercialisation strategy in the UK and US.
FOLLOWING a whirlwind year of acquisitions, fund raises and a debut on the NASDAQ stock exchange, IM Cannabis (IMC) is
MGC Pharma has received approval for a dose finding study for its proprietary treatment for the effects of COVID-19.
MGC Pharma has signed a Supply and Distribution Agreement with AMC Holdings.
MGC Pharmaceuticals has received a Free Trade Certificate in Germany for its product ArtemiC which has shown successful results in
The company’s experimental treatment for severe epilepsy will be covered by the health service.
Two medical patients have revealed the role the treatment has played in their lives at an industry conference.
Danish politicians have agreed to extend a medical cannabis programme – and North America’s giants are watching
Canadian company Zyus’ deal to enter Portugal is another indication the global industry is watching Europe
How an Israel-based company made history by listing on the London Stock Exchange
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.